Saturday 17 October 2026
Export GRDX’s income statement to Excel — free account
GridAI Technologies Corp.
GRDX Healthcare Biotechnology
GridAI Technologies Corp.’s revenue for fiscal 2025 (year ended December 2025) was $36,300.00. In the quarter to June 2026, EPS fell 219.0%, free cash flow fell 2,641.0% and total debt fell 64.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
4.22
0.24
−5.38%
Follow GRDX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | — | — | — | — | — | — | — | — |
Altman Z-Score |
(6.58) | — | — | — | — | — | — | — | — | — |
P/S ratio |
0.00 | — | — | — | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(15.16) | — | — | — | — | — | — | — | — | — |
P/FCF ratio |
0.00 | — | — | — | — | — | — | — | — | — |
P/Operating CF |
(1.90) | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.30 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | — | — | — | — | — | — | — | — | — |
EV/Sales |
0.00 | — | — | — | — | — | — | — | — | — |
EV/EBITDA |
0.00 | — | — | — | — | — | — | — | — | — |
EV/Operating CF |
(2.33) | — | — | — | — | — | — | — | — | — |
EV/FCF |
(2.34) | — | — | — | — | — | — | — | — | — |
Quick Ratio |
0.15 | 0.01 | 1.18 | 0.59 | 0.67 | 0.43 | 0.66 | 1.43 | 0.68 | 1.17 |
Current Ratio |
0.17 | 3.03 | 1.58 | 1.37 | 0.77 | 0.51 | 0.80 | 1.60 | 0.79 | 1.27 |
Net Debt/EBITDA |
0.10 | (1.46) | 0.24 | 0.05 | 0.13 | 0.21 | (0.07) | 0.07 | 0.03 | 0.29 |
Debt/Assets |
0.55% | 26.86% | 0.00% | 12.31% | 6.10% | 4.72% | 12.10% | 3.41% | 4.70% | 2.30% |
Debt/Equity |
0.01 | 0.40 | 0.00 | 0.24 | (0.09) | (0.23) | 0.23 | 0.06 | 0.16 | 0.05 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.85 | 0.50 | 0.77 | 1.49 | 0.38 | 0.27 | 0.92 | 0.80 | 0.65 | 0.31 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (0.02) | 0.15 | (0.02) | (0.38) | (0.04) | (0.02) |
Interest Coverage |
(14.43) | 17,357.00 | (700.92) | (797.36) | (5,272.94) | (4.53) | (33.98) | (131.94) | (11.68) | (1.07) |
| (63.89%) | 13,367.64% | (507.58%) | 589.55% | 1,615.68% | (4,222.85%) | (333.90%) | (441.23%) | (455.37%) | 749.10% | |
| (10.05%) | (39.66%) | (261.35%) | (173.81%) | (683.98%) | (382.40%) | (185.41%) | (209.03%) | (181.41%) | (217.15%) | |
ROIC |
(15.70%) | (12.12%) | 0.00% | (386.73%) | 0.00% | 0.00% | (166.99%) | (232.25%) | (475.14%) | (247.90%) |
Return on Tangible Assets |
53.57% | (32.72%) | (876.36%) | (1,538.70%) | 3,016.04% | 545.00% | 1,897.45% | (699.99%) | 2,827.11% | (1,883.29%) |
Average Days of Receivables |
13,463.77 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
2,549.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
15,152.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.90 | 0.02 | 0.24 | 0.31 | 0.16 | 0.38 | 0.59 | 0.30 | 0.56 | 0.49 |
Share Based Compensation of Revenue |
2,022.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(2.27) | — | — | — | — | — | — | — | — | — |
Graham Number |
0.00 | — | — | — | — | — | — | — | — | — |
Earnings Yield |
(98.15%) | — | — | — | — | — | — | — | — | — |
Free Cash Flow Yield |
(75.42%) | — | — | — | — | — | — | — | — | — |
Revenue per Share |
0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(3.53) | (8.05) | (110.42) | (1,862.01) | (46,126.00) | (56,107.50) | (0.63) | (0.70) | (0.68) | (0.70) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (99.29) | 437.00 | 0.00 | (0.02) | 0.00 | 0.00 |
Free Cash Flow per Share |
(3.53) | (8.05) | (110.42) | (1,862.01) | (46,225.29) | (55,670.50) | (0.63) | (0.72) | (0.68) | (0.70) |
Cash per Share |
0.56 | 0.14 | 33.11 | 113.58 | 11,783.86 | 30,310.50 | 0.01 | 0.07 | 0.05 | 0.27 |
Shareholders Equity per Share |
17.83 | 50.48 | 32.14 | 228.52 | (11,173.71) | (13,203.50) | 0.21 | 0.29 | 0.16 | 0.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.83 | 50.48 | 32.14 | 228.52 | (11,173.71) | (13,203.50) | 0.21 | 0.29 | 0.16 | 0.49 |
Free Cash Flow |
(5.70) | (9.22) | (12.38) | (22.34) | (32.36) | (11.13) | (14.06) | (11.17) | (7.22) | (4.55) |
Working Capital |
(12.56) | 55.93 | 1.82 | 0.93 | (2.88) | (7.68) | (0.88) | 1.80 | (0.53) | 0.62 |
Capital Expenditures |
— | — | — | — | (0.07) | 0.09 | (0.02) | (0.31) | (0.03) | (0.01) |
Net Current Asset Value |
(17.12) | 55.87 | 1.68 | 0.72 | (10.19) | (7.69) | (0.88) | 1.80 | (1.87) | (0.58) |
EV/EBIT |
0.00 | — | — | — | — | — | — | — | — | — |
Capex to Sales |
0.00 | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | — | — | — | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 2.01 | 0.67 | 39.59 | 30.89 | 13.18 | 6.19 | 5.63 | 4.85 |
Cash ROIC |
(19.01%) | (11.39%) | (169.22%) | (467.97%) | (2,822.80%) | (276.20%) | (239.49%) | (191.24%) | (289.66%) | (88.44%) |
Accounts Receivable Turnover |
0.05 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.22 | 0.00 | 0.00 | 0.06 | 0.24 | 0.29 | 0.39 | 0.33 | 0.36 | 0.41 |
Inventory Turnover |
0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
1,779.22 | 0.00 | 0.00 | 2,474.58 | 1,839.06 | 1,077.30 | 854.82 | 1,252.86 | 994.94 | 1,082.58 |
Days of Inventory on Hand |
0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.72 | — | — | 0.32 | — | 1.59 | 2.91 | 2.14 | 1.03 | 1.02 |
Average Payables |
3.17 | 1.76 | 0.64 | 1.71 | 2.20 | 1.99 | 2.51 | 2.40 | 2.12 | 1.80 |
Average Assets |
66.98 | 46.15 | 6.16 | 8.61 | 12.36 | 10.91 | 8.19 | 6.47 | 6.12 | 6.72 |
Average Common Equity |
10.53 | (0.14) | 3.17 | (2.54) | (5.23) | 0.99 | 4.55 | 3.07 | 2.44 | (1.95) |
Columns are period end dates · fundamentals updated 2 Oct 2026